about
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well...
Read More
5.89
-0.61
(-9.38%)
7.7M
XNAS Volume
XNAS 16 Jul, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Annexon Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..